Labor Outcomes in Patients with Diabetes Mellitus Due to Insulin Injection Method

Klimets S. P.
student, medical faculty¹

Agliullina T. F.
Clinical resident, Chair of Endocrinology¹

Avzaletdinova D. S.
Associate Professor, Chair of Endocrinology¹

Stepanova E. M.
Associate Professor, Chair of Endocrinology¹

Morugova T. V.
Head, Department of Endocrinology, Professor¹

Khusainova L. N.
Head, Therapeutical Department²

Reshetnikova L. R.
Head, Obstetric Department²

1 - Bashkir State Medical University
2 - Clinic of the Bashkir State Medical University

Abstract. The aim of study was to analyze pregnancy outcomes in diabetes mellitus women with respect to insulin injection method (insulin pump or pen). The material of study was 52 case reports of labor in women with diabetes in anamnesis. Glycosylated hemoglobin (HbA1c) was at target level in 88% women using pump during pregnancy and only in 18,5% in women using pen (p<0,0001). Mean term of childbirth in the first group was 39,2±0,6 weeks (full-term pregnancy) vs. 36,4±0,6 weeks in the second group (premature birth), р<0,001. Newborns of first group had birth weight 3 278±153 grams, while this parameter in the second group was 3 810±157 grams (р<0,0001). Newborns from the first group were healthy in 92,6% of cases but only 40,8% of second group children were healthy (р=0,0001). Thus, using pump insulin therapy improves delivery outcomes in women with diabetes compared with insulin pens.

diabetes mellitus, pregnancy, insulin pump

10.29234/2308-9113-2017-5-4-58-63

1. Alimetova, Z. R., and F. V. Valeeva. «Stabil'nost' citomembran pochek u beremennyh s saharnym diabetom 1 tipa i iskhody beremennosti v zavisimosti ot sposoba vvedeniya insulina [Stability of kidney cytomebras in pregnant women with type 1 diabetes mellitus and pregnancy outcomes, depending on the mode of insulin administration].» Saharnyj diabet, no. 4 (2012): 69-73.

2. Ruyatkina, L. A., and M. Yu Sorokin. «Vozmozhnosti primeneniya insulina detemir pri lechenii saharnogo diabeta u beremennyh: dokazannye preimushchestva i perspektivy ispol'zovaniya [Possibilities of using insulin detemir in the treatment of diabetes mellitus in pregnant women: the proven benefits and prospects of using].» Saharnyj diabet, no. 2 (2016): 171-78.

3. Tiselko, A. V. «Mezhdunarodnyj simpozium »Diabet, Gipertoniya, Metabolicheskij sindrom i Beremennost'«, 13–16 marta 2013 g., Florenciya, Italiya [International Symposium »Diabetes, Hypertension, Metabolic Syndrome and Pregnancy«, March 13-16, 2013, Florence, Italy].» Saharnyj diabet 16, no. 1 (2013): 106-07.

4. Demidova, I. Y., N. Y. Arbatskaya, and E. P. Melnikova. «Selection of insulin therapy method in pregnant women with type 1 diabetes mellitus.» Farmateka, no. 17 (2008): 76-82.

5. Barnard, K. D., C. E. Lloyd, and T. C. Skinner. «Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes.» Diabetic Medicine24, no. 6 (2007): 607-17. doi:10.1111/j.1464-5491.2007.02120.x.

6. Misso, Marie L., Denise Oconnor, Kristine J. Egberts, and Jonathan Shaw. «Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.» Cochrane Database of Systematic Reviews, 2005. doi:10.1002/14651858.cd005103.

7. Esayan, R., Degtyareva E., Shestakova M. Insulin pumptherapy in patients with type 1 diabetes mellitus duringpregnancy and labor. The 6th International Symposium on Diabetes and Pregnancy (DIP 2011). Salzburg, Austria, March 2011; Abstr. 514.

8. Ansaldi, E. et al. Insulin pump during labour and delivery: a preliminary experience. The 6th International Symposium on Diabetes and Pregnancy (DIP 2011). Salzburg, Austria, March 2011; Abstr. 369.

9. Guilhem, I., B. Balkau, F. Lecordier, J.-M. Malécot, S. Elbadii, A.-M. Leguerrier, J.-Y. Poirier, C. Derrien, and F. Bonnet. «Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007.» Diabetologia 52, no. 12 (2009): 2662-664. doi:10.1007/s00125-009-1549-7.

10. Tiselko, A., Potin V., Borovik N. Continuous subcutaneous insulin infusion (CSII),continuous glucose monitoring (CGM) in type 1 diabetes mellitus (DM1) patients during pregnancy and delivery. The 6th International Symposium on Diabetes in Pregnancy (DIP 2011). Salzburg, Austria, March 2011; Abstr. 332.

11. Webster, D., Ulahannan T. Review of pregnancy outcomes in diabetic women on continuous subcutaneous. The 6th International Symposium on Diabetes and Pregnancy (DIP 2011). Salzburg, Austria, March 2011; Abstr. 351.

12. Weissberg-Benchell, J., J. Antisdel-Lomaglio, and R. Seshadri. «Insulin Pump Therapy: A meta-analysis.» Diabetes Care26, no. 4 (2003): 1079-087. doi:10.2337/diacare.26.4.1079.